Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry. (Q45977906)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry. |
scientific article |
Statements
1 reference
Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry. (English)
1 reference
1 reference
A Haouala
1 reference
B Zanolari
1 reference
B Rochat
1 reference
M Montemurro
1 reference
K Zaman
1 reference
M A Duchosal
1 reference
H B Ris
1 reference
S Leyvraz
1 reference
L A Decosterd
1 reference
13 May 2009
1 reference
877
1 reference
22
1 reference
1982-1996
1 reference